Because LRP1 has been shown to play a significant role in orchestrating both activation and inhibition signals in various cells of both the innate and adaptive immune systems, we believe that this molecule can serve as an important target for exploration of novel anti-GVHD treatment strategies. The gene discussed is LRP1; the disease is graft versus host disease.